Cargando…
Liver cell cancer /
Liver Cell Cancer focuses on liver cell cancer, which is considered one of the most aggressive malignant tumors, and in turn, one of the most intensively studied tumors in man and experimental animals. This book discusses the geographic pathology, alpha-fetoprotein, diagnosis, treatment, and backgro...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; New York :
Elsevier Scientific Pub. Co.,
1976.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; Liver Cell Cancer; Copyright Page; LIST OF CONTRIBUTORS; PREFACE; Table of Contents; Chapter 1. THE GEOGRAPHIC PATHOLOGY OF LIVER CELL CANCER; SUMMARY; 1.1. THE GLOBAL PATTERN OF LIVER CELL CANCER; 1.2 NOMENCLATURE AND CLASSIFICATION; 1.3 DESCRIPTIVE EPIDEMIOLOGY
- RATIO STUDIES; 1.4 INCIDENCE STUDIES; 1.5 THE INFLUENCE OF SEX AND AGE ON THE INCIDENCE OF LIVER CELL CANCER; 1.6 TIME TRENDS; 1.7 ASSOCIATED DISEASES AND THEIR GEOGRAPHY; REFERENCES; Chapter 2. THE PATHOLOGY OF LIVER CELL CANCER; SUMMARY; 2.1 GROSS PATHOLOGY; 2.2 MICROSCOPIC PATHOLOGY; 2.3 DIFFERENTIAL DIAGNOSIS.
- 2.4 ULTRASTRUCTURE2.5 SPREAD OF TUMOUR; 2.6 ASSOCIATION OF LIVER CELL CANCER WITH OTHER DISEASES; 2.7 ASSOCIATION OF LIVER CELL CANCER WITH HORMONAL ABNORMALITIES (THE 'ECTOPIC HORMONE SYNDROMES'); 2.8 COURSE AND MODE OF DEATH; REFERENCES; Chapter 3. THE CLINICAL PROBLEM OF LIVER CELL CANCER IN A HIGH INCIDENCE AREA; SUMMARY; 3.1 AGE; 3.2 SEX; 3.3 CLINICAL FEATURES; 3.4 LABORATORY INVESTIGATIONS; 3.5 SPECIAL INVESTIGATIONS; 3.6 DIFFERENTIAL DIAGNOSIS; 3.7 MANAGEMENT; REFERENCES; Chapter 4. ALPHA-FETOPROTEIN AND THE DIAGNOSIS OF LIVER CELL CANCER; SUMMARY.
- 4.1 THE PHYSIOLOGY OF ALPHA-FETOPROTEIN4.2 THE SIGNIFICANCE OF RAISED ALPHA-FETOPROTEIN LEVELS; 4.3 SURVEYS FOR LIVER CELL CANCER DETECTION; REFERENCES; Chapter 5. THE TREATMENT OF LIVER CELL CANCER; SUMMARY; 5.1 SURGERY: HEPATIC RESECTION; 5.2 HEPATIC ARTERIAL CATHETERIZATION; 5.3 RADIOTHERAPY: EXTERNAL IRRADIATION; 5.4 RADIOTHERAPY AND CHEMOTHERAPY; 5.5 PLACEBO; 5.6 CYTOSTATICS; 5.7 HOPE FOR THE FUTURE; REFERENCES; Chapter 6. THE BACKGROUND TO LIVER CELL CANCER; SUMMARY; 6.1 THE BACKGROUND TO LIVER CELL CANCER; 6.2 RACE, SEX AND GENETICS; 6.3 MALNUTRITION; 6.4 LIVER DISEASE OF THE ALCOHOLIC.
- 6.5 IRON OVERLOAD6.6 PARASITES; 6.7 NATURALLY OCCURRING CARCINOGENS; 6.8 DRUGS AND CHEMICALS; 6.9 VIRAL HEPATITIS; REFERENCES; Chapter 7. THE INDUCTION OF LIVER CELL CANCER BY CHEMICALS; SUMMARY; 7.1 INTRODUCTION; 7.2 NATURALLY OCCURRING LIVER CARCINOGENS; 7.3 SYNTHETIC LIVER CARCINOGENS; REFERENCES; Chapter 8. CELL PROLIFERATION AND EXPERIMENTAL LIVER CANCER; SUMMARY; 8.1. INTRODUCTION; 8.2 RELATION BETWEEN HEPATOCYTE PROLIFERATION AND SENSITIVITY TO CARCINOGENS IN NORMAL ADULT ANIMALS; 8.3 EXPERIMENTS WITH YOUNG ANIMALS; 8.4 STIMULATION OF DNA SYNTHESIS AND CELL REPLICATION BY CARCINOGENS.
- 8.5 STIMULATION OF LIVER CELL REPLICATION IN RELATION TO SENSITIVITY TO CARCINOGENS8.6 STUDIES OF THE MECHANISMS BY WHICH CELL PROLIFERATION INFLUENCES CARCINOGENESIS; 8.7 SIGNIFICANCE OF THE INCREASED SENSITIVITY OF REPLICATING CELLS TO CARCINOGENS; REFERENCES; Chapter 9. IMMUNOLOGY OF EXPERIMENTAL LIVER CELL CANCER; SUMMARY; 9.1 INTRODUCTION; 9.2 TUMOUR-ASSOCIATED REJECTION ANTIGENS; 9.3 TUMOUR-SPECIFIC CELL SURFACE ANTIGENS; 9.4 TUMOUR-ASSOCIATED EMBRYONIC ANTIGENS; 9.5 NEOANTIGENS ASSOCIATED WITH CELLS TRANSFORMED IN VITRO BY CHEMICAL CARCINOGENS; 9.6 'ABNORMAL' TUMOUR ANTIGENS.